Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chronic Kidney Disease
65%
Intact Parathyroid Hormone (iPTH)
49%
Post-transplant Lymphoproliferative Disorder
43%
Pediatric
42%
Kidney
38%
Kidney Transplant
31%
Kidney Transplantation
30%
Osteoclast
28%
Vascular Calcification
26%
Pediatric Kidney Transplantation
24%
Pediatric Nephrology
22%
Ca2+
21%
Continuous Renal Replacement Therapy
19%
CKD-MBD
19%
Kidney Disease
19%
Bone Morphogenetic protein-7 (BMP-7)
18%
Older Adults
18%
Osteopontin
18%
Hypertension
17%
Midwest
16%
Immunosuppression
15%
Cytosolic Calcium
15%
Pediatric Kidney Transplant Recipients
14%
Renal Transplantation
14%
Transplantation
13%
North America
13%
Bone Disease
13%
United States
13%
Pretransplant
12%
Renal Osteodystrophy
12%
Bone Resorption
12%
Integrin
12%
Blood Pressure
12%
Acute Rejection
12%
Escherichia Coli
12%
High Risk
11%
Urinary Tract Infection
11%
Kidney Transplant Recipients
11%
Acute Kidney Injury
11%
Estimated Glomerular Filtration Rate
10%
Risk Factors
10%
Renal Injury
10%
Osteoblast
10%
Pediatric Patients
10%
95% Confidence Interval
10%
Lupus Nephritis
10%
Na +
9%
Onasemnogene Abeparvovec
9%
Osteoblast-like
9%
Uropathogenic Escherichia Coli
9%
African American
9%
Hyperphosphatemia
9%
Diabetes
9%
End-stage Renal Disease
9%
Adjusted Hazard Ratio
9%
Solid Organ Transplantation
8%
Pediatric Dialysis
8%
Liver
8%
Epstein-Barr Virus
8%
Dialysis
8%
Patient Survival
8%
Vitamin D
8%
Canine
8%
First Year
7%
Graft Survival
7%
Knock-in Mouse Model
7%
Transplant Recipients
7%
1,25(OH)2D3
7%
Hemodialysis
7%
BK Polyomavirus (BKPyV)
7%
Glomerular Filtration Rate
7%
Renal Transplant Recipients
7%
Podosome
7%
COVID-19
7%
Vasculature
7%
Secondary Hyperparathyroidism
7%
Nephrotic Syndrome
7%
Hospitalization
7%
Phosphate
7%
Endothelial Cells
7%
Uremia
6%
Serum Creatinine
6%
Renal Replacement
6%
Vascular Access
6%
Plasma Membrane
6%
Cyclic Adenosine Monophosphate (cAMP)
6%
Gelsolin
6%
Epidemiology
6%
Kidney Function
6%
Vascular Smooth muscle Cells
6%
Pediatric Chronic Kidney Disease
6%
Phosphate Transport
6%
Nephrology Research
6%
Research Consortium
6%
Graft Failure
6%
Bone Formation
6%
Collaborative Study
6%
Osteoclast Differentiation
6%
Study within a Trial
6%
Fibroblast Growth Factor 23 (FGF23)
6%
Medicine and Dentistry
Pediatrics
100%
Chronic Kidney Disease
76%
Kidney Transplantation
56%
Kidney Graft
56%
Nephropathy
39%
Posttransplant Lymphoproliferative Disease
36%
Parathyroid Hormone
29%
Blood Vessel Calcification
24%
Bone Disease
22%
Immunosuppressive Treatment
22%
Pediatric Nephrology
22%
Diseases
21%
Adolescence
21%
Infection
20%
Osteogenic Protein 1
20%
Hypertension
19%
Hemodialysis
19%
Acute Kidney Injury
18%
Kidney Function
18%
Graft Failure
14%
Creatinine
14%
Isotopes of Calcium
13%
End Stage Renal Disease
13%
Pediatrics Patient
13%
Graft Survival
12%
Glomerular Filtration Rate
12%
Allograft
12%
Continuous Renal Replacement Therapy
12%
Epstein Barr Virus
11%
Solid Organ Transplantation
10%
Renal Osteodystrophy
10%
Kidney Injury
10%
Blood Pressure
10%
Hyperphosphatemia
10%
Biological Marker
10%
Diabetes
10%
Hazard Ratio
9%
Chronic Kidney Disease-Mineral and Bone Disorder
9%
Bone Density
9%
Cardiovascular Risk
9%
Osteoblast
9%
Renal Replacement
9%
Fibroblast Growth Factor 23
8%
Renal Replacement Therapy
8%
Biopsy Technique
8%
Medicare
8%
Pathophysiology
8%
Cohort Effect
8%
Cohort Analysis
8%
Vascular Access
8%
Arteriovenous Fistula
8%
Proteinuria
8%
Nephrotic Syndrome
8%
Renal Failure
8%
Acute Graft Rejection
7%
BK Virus
7%
Thymocyte Antibody
7%
Steroid
7%
Lupus Nephritis
7%
Health Care Cost
7%
Atherosclerotic Plaque
7%
Ossification
7%
Calcium Ion
6%
Glomerulonephritis
6%
Cardiovascular Disease
6%
Glomerulopathy
6%
Bone Morphogenetic Protein
6%
Immunosuppressive Drug
6%
Bone Remodeling
6%
Maturity Onset Diabetes of the Young
6%
Deceased Donors
6%
Prevalence
6%
Urinary Tract Infection
6%
Renal Biopsy
5%
Pathogenesis
5%
Morbidity
5%
Cancer
5%
Odds Ratio
5%
Calcitriol
5%
In Vitro
5%
Genetics
5%
Rituximab
5%
Continuous Kidney Replacement Therapy
5%
Mineralization
5%
Kidney Allograft
5%
Osteodystrophy
5%
Inflammation
5%
Clinical Trial
5%
Chemotherapy
5%
Sepsis
5%
Urinary System
5%
Intensive Care Unit
5%
Central Venous Catheter
5%